Full Schedule

9:00 AM – 9:15 AM ET

Welcome

Co-Chair: – Vanderbilt-Ingram Cancer Center

Co-Chair: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

9:15 AM – 9:30 AM ET

Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX

Presenter: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

9:30 AM – 9:45 AM ET

Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX

Presenter: – MD Anderson Cancer Center, The University of Texas

9:45 AM – 10:00 AM ET

Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - Discussion

Moderator: – Vanderbilt-Ingram Cancer Center

Panelist: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Panelist: – MD Anderson Cancer Center, The University of Texas

10:00 AM – 10:15 AM ET

Break

10:15 AM – 10:30 AM ET

Session 16: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Yes

Presenter: – Northwell Health Cancer Institute

10:30 AM – 10:45 AM ET

Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - No

Presenter: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center

10:45 AM – 11:00 AM ET

Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Discussion

Moderator: – Vanderbilt-Ingram Cancer Center

Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Panelist: – Northwell Health Cancer Institute

Panelist: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center

11:00 AM – 11:15 AM ET

Break

11:15 AM – 11:50 AM ET

Session 17: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies

Presenter: – MD Anderson Cancer Center, The University of Texas

11:50 AM – 12:00 PM ET

Live Q&A

Moderator: – Vanderbilt-Ingram Cancer Center

Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Speaker: – MD Anderson Cancer Center, The University of Texas

12:15 PM – 12:30 PM ET

Break

12:30 PM – 1:05 PM ET

Session 18: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric

Presenter: – Vanderbilt-Ingram Cancer Center

1:05 PM – 1:15 PM ET

Live Q&A

Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Speaker: – Vanderbilt-Ingram Cancer Center

1:15 PM – 1:30 PM ET

Break

1:30 PM – 2:15 PM ET

Session 19: Determination of Treatment Patterns in HCC

Presenter: – Memorial Sloan Kettering Cancer Center

2:15 PM – 2:30 PM ET

Break

2:30 PM – 3:15 PM ET

Session 20: Role of Interventional Radiology in the Management of NETs

Presenter: – Stanford School of Medicine

3:15 PM – 3:30 PM ET

Break

3:30 PM – 4:15 PM ET

Session 21: Significance of Cancer Genetics

Presenter: – University of Chicago

4:15 PM – 4:20 PM ET

Closing Remarks

Co-Chair: – Vanderbilt-Ingram Cancer Center

Co-Chair: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center